Biosyent Inc (RX_CDNX)
RX_CDNX moved a median of 0.00% 30 minutes after news, and +0.41% by the close. How RX_CDNX actually reacts to news — the realized, point-in-time move the market made, measured across 62 labeled events over the last three years with zero look-ahead.
RX_CDNX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 22% | 23 |
| 30-min | 0.00% | 33% | 24 |
| 60-min | 0.00% | 38% | 24 |
| to close | +0.41% | 54% | 24 |
| Middle 50% of RX_CDNX reactions | 0.00% to +1.06% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 62 |
Half of all Biosyent Inc news events land between +0.00% and +1.06% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when RX_CDNX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to RX_CDNX's baseline. Nothing else.
Recent RX_CDNX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| BioSyent Named as One of Canada’s Top Growing Companies 2026 by The Globe and Mail | Press release | GlobeNewswire | — | — | |
| BioSyent Declares Third Quarter 2026 Dividend | Press release | GlobeNewswire | — | — | |
| BioSyent Releases Financial Results for Q2 and H1 2026 | Press release | GlobeNewswire | — | — | |
| BioSyent Schedules Q2 and H1 2026 Earnings Release for August 20, 2026 | Press release | GlobeNewswire | — | — | |
| BioSyent to Present at Planet MicroCap Las Vegas | Press release | GlobeNewswire | — | — | |
| BioSyent Announces Health Canada Approval of Thyconvi™ (levothyroxine oral solution) | Press release | GlobeNewswire | — | — | |
| BioSyent Declares Second Quarter 2026 Dividend | Press release | GlobeNewswire | — | — | |
| BioSyent Releases Financial Results for First Quarter 2026 | Press release | GlobeNewswire | — | — | |
| BioSyent Schedules First Quarter 2026 Earnings Release for May 14, 2026 | Press release | GlobeNewswire | — | — | |
| BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference | Press release | GlobeNewswire | — | — | |
| FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years | Press release | GlobeNewswire | — | — | |
| BioSyent Announces Grant of Restricted Share Units | Press release | GlobeNewswire | — | — | |
| BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025 | Press release | GlobeNewswire | — | — | |
| BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026 | Press release | GlobeNewswire | — | — | |
| BioSyent Announces Closing of the Acquisition of Oral Science Inc. | Press release | GlobeNewswire | — | — | |
| BioSyent to Acquire Oral Science Inc. | Press release | GlobeNewswire | — | — | |
| BioSyent Declares First Quarter 2026 Dividend | Press release | GlobeNewswire | — | — | |
| BioSyent Announces Renewal of Normal Course Issuer Bid | Press release | GlobeNewswire | — | — | |
| BioSyent Declares Fourth Quarter 2025 Dividend | Press release | GlobeNewswire | — | — | |
| BioSyent Releases Financial Results for Q3 and YTD 2025 | Press release | GlobeNewswire | — | — | |
| BioSyent Declares Third Quarter 2025 Dividend | Press release | GlobeNewswire | — | — | |
| BioSyent Releases Financial Results for Q2 and H1 2025 | Press release | GlobeNewswire | — | — | |
| BioSyent Schedules Q2 and H1 2025 Earnings Release for August 21, 2025 | Press release | GlobeNewswire | — | — | |
| BioSyent Declares Second Quarter 2025 Dividend | Press release | GlobeNewswire | — | — | |
| BioSyent Releases Financial Results for First Quarter 2025 | Press release | GlobeNewswire | — | — | |
| BioSyent Schedules First Quarter Earnings Release for May 15, 2025 | Press release | GlobeNewswire | — | — | |
| BioSyent to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference | Press release | GlobeNewswire | — | — | |
| BioSyent to Attend Planet MicroCap Showcase | Press release | GlobeNewswire | — | — | |
| FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Tenth Consecutive Year | Press release | GlobeNewswire | — | — | |
| BioSyent Announces Grant of Restricted Share Units | Press release | GlobeNewswire | — | — | |
| BioSyent Releases Financial Results for Fourth Quarter and Full Year 2024 | Press release | GlobeNewswire | — | — | |
| BioSyent Schedules Fourth Quarter and Full Year 2024 Earnings Release for March 13, 2025 | Press release | GlobeNewswire | — | — | |
| BioSyent Declares First Quarter 2025 Dividend | Press release | GlobeNewswire | — | — | |
| FAX Capital Files Early Warning Report Regarding Disposition of Common Shares of BioSyent Inc. | Press release | GlobeNewswire | — | — | |
| BioSyent Announces Renewal of Normal Course Issuer Bid | Press release | GlobeNewswire | — | — | |
| FAX Capital Files Early Warning Report Regarding Disposition of Common Shares of BioSyent Inc. | Press release | GlobeNewswire | — | — | |
| BioSyent Declares Fourth Quarter 2024 Dividend | Press release | GlobeNewswire | — | — | |
| BioSyent Releases Financial Results for Q3 and YTD 2024 | Press release | GlobeNewswire | — | — | |
| BioSyent Schedules Q3 and YTD 2024 Earnings Release for November 20, 2024 | Press release | GlobeNewswire | — | — | |
| BioSyent Announces Agreement to Purchase Tibelia® (tibolone) Assets | Press release | GlobeNewswire | +1.21% | +2.33% | |
| BioSyent Declares Third Quarter 2024 Dividend | Press release | GlobeNewswire | +0.10% | +2.02% | |
| BioSyent Releases Financial Results for Q2 and H1 2024 | Press release | GlobeNewswire | +0.10% | +2.02% | |
| FAX Capital Files Early Warning Report Regarding Disposition of Common Shares of BioSyent Inc. | Press release | GlobeNewswire | +0.00% | +0.00% | |
| BioSyent In-Licenses Endocrinology Product for Canada | Press release | GlobeNewswire | +0.00% | +1.07% | |
| BioSyent Declares Second Quarter 2024 Dividend | Press release | GlobeNewswire | +0.11% | +2.04% | |
| BioSyent Releases Financial Results for Q1 2024 | Press release | GlobeNewswire | +0.11% | +2.04% | |
| BioSyent Schedules Q1 2024 Earnings Release for May 16, 2024 | Press release | GlobeNewswire | +0.00% | -1.16% | |
| BioSyent to Attend Planet MicroCap Showcase | Press release | GlobeNewswire | +0.00% | -0.47% | |
| BioSyent Announces Extension of RepaGyn® and Proktis-M® Agreement | Press release | GlobeNewswire | +0.00% | +0.35% | |
| BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference | Press release | GlobeNewswire | +0.00% | -0.23% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the RX_CDNX section they belong to.
Where else RX_CDNX is measured.
RX_CDNX earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| LIFT & CO CORP (LIFT_CDNX) | 62 | -0.52% | 27% |
| PLANDAI BIOTECHNOLOGY INC (PLPL) | 62 | 0.00% | 41% |
| Seagen Inc. (SGEN) | 62 | -0.01% | 48% |
| THERAPEUTIC SLTNS INTL (TSOI) | 62 | 0.00% | 28% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Biosyent Inc's median reaction calculated?
Every labeled RX_CDNX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 62 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 33% of RX_CDNX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does RX_CDNX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.